Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
GOCOVRI ® - These highlights do not include all the information needed to use GOCOVRI ®safely and effectively. See full prescribing information for GOCOVRI. GOCOVRI ®(amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968
Medication labelWhy this: Advisory · dailymed-prescription
GOCOVRI ®is indicated: For the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications As adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing "off" episodes
- generic_name
- amantadine
- product_names
- AMANTADINE
- ndc
- 70482-085, 70482-085-60, 70482-085-21, 70482-085-61, 70482-170, 70482-170-60, 70482-170-21, 70482-170-61
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en